Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Leigh · SciRah

Researcher profile · Semantic Scholar

B. Leigh

Share profile

B. Leigh — researcher profile on SciRah

h-index: 22
Works: 69
Citations: 1,988

Most-cited papers

Radiation dosimetry results and safety correlations from 90Y-ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from 4 clinical trials.
G. Wiseman, E. Kornmehl, B. Leigh, W. Erwin +6 more
2003Journal of Nuclear Medicine226 citations
Semantic Scholar
Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
G. Wiseman, C. White, R. Sparks, W. Erwin +9 more
2001Critical reviews in oncology/hematology186 citations
Semantic Scholar
Phase I/II study of galiximab, an anti-CD80 antibody, for relapsed or refractory follicular lymphoma.
M. Czuczman, A. Thall, T. Witzig, J. Vose +10 more
2005Journal of Clinical Oncology155 citations Open access
Semantic Scholar
A Phase 1 First-in-Human Study of TRC105 (Anti-Endoglin Antibody) in Patients with Advanced Cancer
L. Rosen, H. Hurwitz, M. Wong, J. Goldman +9 more
2012Clinical Cancer Research146 citations Open access
Semantic Scholar
Positron Emission Tomography Imaging of CD105 Expression with a 64Cu-Labeled Monoclonal Antibody: NOTA Is Superior to DOTA
Yin Zhang, H. Hong, J. Engle, Jero Bean +4 more
2011PLoS ONE128 citations Open access
Semantic Scholar
Phase 1 Study of Lumiliximab with Detailed Pharmacokinetic and Pharmacodynamic Measurements in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
J. Byrd, S. O'Brien, I. Flinn, T. Kipps +9 more
2007Clinical Cancer Research109 citations Open access
Semantic Scholar
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia.
J. Byrd, T. Kipps, I. Flinn, J. Castro +11 more
2010Blood106 citations Open access
Semantic Scholar
Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma
G. Wiseman, B. Leigh, W. Erwin, D. Lamonica +6 more
2002Cancer92 citations Open access
Semantic Scholar
Positron emission tomography imaging of CD105 expression with89 Zr-Df-TRC105
H. Hong, G. Severin, Yu-Nan Yang, J. Engle +6 more
2011European Journal of Nuclear Medicine and Molecular Imaging70 citations Open access
Semantic Scholar
Positron emission tomography imaging of CD105 expression during tumour angiogenesis
H. Hong, Yu-Nan Yang, Yin Zhang, J. Engle +4 more
2011European Journal of Nuclear Medicine and Molecular Imaging69 citations Open access
Semantic Scholar
Multimodality Imaging of Breast Cancer Experimental Lung Metastasis with Bioluminescence and a Monoclonal Antibody Dual-Labeled with 89Zr and IRDye 800CW
H. Hong, Yin Zhang, G. Severin, Yu-Nan Yang +7 more
2012Molecular Pharmaceutics68 citations Open access
Semantic Scholar
Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy
S. Denardo, P. Burke, B. Leigh, R. O'Donnell +7 more
2000Cancer Biotherapy and Radiopharmaceuticals62 citations
Semantic Scholar
Identification of a high-risk clinically localized prostate cancer subgroup receiving maximum benefit from whole-pelvic irradiation.
S. Seaward, V. Weinberg, P. Lewis, B. Leigh +2 more
1998The cancer journal from Scientific American50 citations
Semantic Scholar
ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW.
Yin Zhang, H. Hong, G. Severin, J. Engle +8 more
2012American journal of translational research49 citations
Semantic Scholar
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
A. Davies, K. Chansky, D. Lau, B. Leigh +5 more
2006Journal of Clinical Oncology42 citations
Semantic Scholar
In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis
Yu-Nan Yang, Yin Zhang, H. Hong, Glenn Liu +2 more
2011European Journal of Nuclear Medicine and Molecular Imaging39 citations Open access
Semantic Scholar
Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
M. Edelman, K. Chansky, L. Gaspar, B. Leigh +5 more
2004Journal of Clinical Oncology39 citations
Semantic Scholar
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors
M. Gordon, L. Rosen, D. Mendelson, R. Ramanathan +11 more
2012Investigational new drugs36 citations Open access
Semantic Scholar
Initial trials of anti-CD80 monoclonal antibody (Galiximab) therapy for patients with relapsed or refractory follicular lymphoma.
A. Younes, K. Hariharan, Roberta S. Allen, B. Leigh
2003Clinical Lymphoma36 citations
Semantic Scholar
Radiation Dosimetry Results From a Phase II Trial of Ibritumomab Tiuxetan (Zevalin™) Radioimmunotherapy for Patients With Non-Hodgkin's Lymphoma and Mild Thrombocytopenia
G. Wiseman, B. Leigh, W. Erwin, R. Sparks +7 more
2003Cancer Biotherapy and Radiopharmaceuticals34 citations
Semantic Scholar
Additional Radiation Absorbed Dose Estimates for Zevalin™ Radioimmunotherapy
G. Wiseman, B. Leigh, W. L. Dunn, M. Stabin +1 more
2003Cancer Biotherapy and Radiopharmaceuticals25 citations
Semantic Scholar
Updated Results from a Phase II Study of Galiximab (Anti-CD80) in Combination with Rituximab for Relapsed or Refractory, Follicular NHL.
J. Friedberg, J. Leonard, A. Younes, D. Fisher +10 more
200523 citations
Semantic Scholar
Safety and Efficacy Results from a Phase I Trial of Single-Agent Lumiliximab (Anti-CD23 Antibody) for Chronic Lymphocytic Leukemia.
J. Byrd, S. O'Brien, I. Flinn, T. Kipps +6 more
200420 citations
Semantic Scholar
Radioimmunotherapy of non-Hodgkin's lymphoma: clinical development of the Zevalin regimen.
C. Theuer, B. Leigh, P. Multani, Roberta S. Allen +1 more
2004Biotechnology Annual Review20 citations
Semantic Scholar
Phase I study of TRC105 (anti-CD105 [endoglin] antibody) therapy in patients with advanced refractory cancer.
D. Mendelson, M. Gordon, L. Rosen, H. Hurwitz +6 more
201019 citations
Semantic Scholar
A phase I trial of stereotactic external beam radiation for subfoveal choroidal neovascular membranes in age-related macular degeneration.
A. Barak, D. Hauser, P. Yipp, L. Morse +5 more
2005British Journal of Radiology17 citations
Semantic Scholar
Pathologic stage IIIb non-small cell lung cancer (NSCLC): Prolonged survival with consoloidation Docetaxel following concurrent chemoradiotherapy (SWOG 9504)
D. Gandara, L. Lovato, K. Albain, B. Leigh +3 more
200016 citations
Semantic Scholar
Severe esophageal toxicity after thoracic radiation therapy for lung cancer associated with the human immunodeficiency virus: a case report and review of the literature.
B. Leigh, D. Lau
1998American Journal of Clinical Oncology16 citations
Semantic Scholar
Final results from a phase I study of TRC093 (humanized anti-cleaved collagen antibody) in patients with solid cancer.
F. Robert, M. Gordon, L. Rosen, D. Mendelson +5 more
201013 citations
Semantic Scholar
Clinical hyperthermia with a new device: the current sheet applicator.
B. Leigh, Baldassarre Stea, J. Cassady, J. Kittelson +1 more
1994International Journal of Radiation Oncology, Biology, Physics11 citations
Semantic Scholar
Early evidence of tolerability and clinical activity from a phase I study of TRC105 (anti-CD105 antibody) in patients with advanced refractory cancer.
L. Rosen, M. Gordon, H. Hurwitz, M. Wong +5 more
2009Journal of Clinical Oncology9 citations
Semantic Scholar
Evolution of combined modality therapy for stage III non-small-cell lung cancer.
D. Gandara, M. Edelman, P. Lara, P. Roberts +1 more
2000Oncology9 citations
Semantic Scholar
111 Clinical experience of breathing synchronized radiotherapy procedure at the University of California Davis Cancer Center
H. Kubo, P. Len, L. Wang, B. Leigh +1 more
19998 citations Open access
Semantic Scholar
Final results from a phase I study of oral TRC102 (methoxyamine HCl), an inhibitor of base-excision repair, to potentiate the activity of pemetrexed in patients with refractory cancer.
G. Weiss, M. Gordon, L. Rosen, P. Savvides +6 more
20107 citations
Semantic Scholar
In vivo near-infrared fluorescence imaging of CD105 expression
Yu-Nan Yang, H. Hong, Yin Zhang, B. Leigh +1 more
20116 citations
Semantic Scholar
A phase I study of daily oral TRC102 (methoxyamine) to enhance the therapeutic effects of pemetrexed in patients with advanced refractory cancer.
S. Anthony, L. Rosen, Glen J. Weiss, M. Gordon +5 more
2016Journal of Clinical Oncology3 citations
Semantic Scholar
Fc-Gamma Receptor IIIa and Interferon-Gamma SNPs Do Not Predict Responsiveness of Follicular Lymphoma to Galiximab (Anti-CD80 Antibody).
M. Czuczman, B. Leigh, T. Witzig, J. Vose +5 more
20043 citations
Semantic Scholar
Pharmacokinetics of Single-Agent Lumiliximab (Anti-CD23 Antibody) in Patients with Chronic Lymphocytic Leukemia.
J. Woodworth, B. Leigh, S. O'Brien, I. Flinn +6 more
20043 citations
Semantic Scholar
Antiproliferative Properties of Toremifene on AIDS-Related Kaposi’s Sarcoma Cells
A. Hong, B. Leigh
2002Chemotherapy3 citations
Semantic Scholar
A phase Ib dose-escalation study of TRC105 in combination with bevacizumab for advanced solid tumors.
D. Mendelson, L. Rosen, F. Robert, E. Chiorean +7 more
20122 citations
Semantic Scholar
Modulation of angiogenic biomarkers in patients treated on a phase I study of TRC105 (anti-CD105 antibody) monotherapy for advanced solid tumors.
Ying-Miao Liu, Mark D. Starr, H. Pang, J. Marcello +4 more
2011Journal of Clinical Oncology2 citations
Semantic Scholar
A phase I study of TRC105 (anti-CD105 monoclonal antibody) in metastatic castration-resistant prostate cancer (mCRPC).
D. Adelberg, A. Apolo, R. Madan, J. Gulley +9 more
2011Journal of Clinical Oncology2 citations
Semantic Scholar
Zevalin radioimmunotherapy is effective for patients with bulky non-Hodgkin’s lymphoma
R. Meredith, B. Leigh, G. Wiseman, E. Kornmehl +6 more
20012 citations Open access
Semantic Scholar
Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998.
B. Leigh, D. Gandara, J. Crowley, K. Furuse +3 more
1999Lung Cancer2 citations
Semantic Scholar
WE-C-217BCD-04: Multimodality Imaging of Breast Cancer Experimental Lung Metastasis.
Yin Zhang, H. Hong, Yu-Nan Yang, Gregory Severin +6 more
2012Medical Physics (Lancaster)1 citations
Semantic Scholar
A phase I study of TRC105 (anti-CD105 antibody) in patients with advanced solid tumors.
J. Goldman, M. S. Gordon, H. Hurwitz, R. Pili +7 more
2011Journal of Clinical Oncology1 citations
Semantic Scholar
517 Combining pemetrexed with temozolomide and TRC102 (methoxyamine) causes synergistic cytotoxicity in melanoma cells
Li-Li Liu, A. Bulgar, B. Adams, C. Theuer +2 more
20101 citations
Semantic Scholar
Abstract B62: A phase 1 study of oral TRC102 (methoxyamine), an inhibitor of base‐excision repair, to potentiate the therapeutic effects of pemetrexed in patients with advanced refractory cancer
M. Gordon, G. Weiss, L. Rosen, D. Mendelson +8 more
20091 citations
Semantic Scholar
282 Phase I trial of concurrent irradiation and bi-weekly paclitaxel for stage III non-small-cell lung cancer☆
D. Lau, D. Gandara, J. Ryu, Robert J. Morgan +3 more
19971 citations
Semantic Scholar
Response to Drs. Adamietz and Boẗtcher
B. Leigh, D. Shimm
19941 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Theuer×13
Invite
C. Theuer — researcher profile on SciRah
B. Adams×11
Invite
B. Adams — researcher profile on SciRah
L. Rosen×10
Invite
L. Rosen — researcher profile on SciRah
D. Alvarez×9
Invite
D. Alvarez — researcher profile on SciRah

×8

Invite

M. Gordon — researcher profile on SciRah

Invite

Yin Zhang — researcher profile on SciRah

Invite

H. Hong — researcher profile on SciRah

Invite

Yu-Nan Yang — researcher profile on SciRah

Invite

W. Cai — researcher profile on SciRah

D. Mendelson×7

Invite

D. Mendelson — researcher profile on SciRah

Invite

T. Witzig — researcher profile on SciRah

Invite

C. White — researcher profile on SciRah